0001181431-12-003409.txt : 20120120 0001181431-12-003409.hdr.sgml : 20120120 20120120213024 ACCESSION NUMBER: 0001181431-12-003409 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120118 FILED AS OF DATE: 20120120 DATE AS OF CHANGE: 20120120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POWELL MICHAEL CENTRAL INDEX KEY: 0001202793 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34828 FILM NUMBER: 12538164 MAIL ADDRESS: STREET 1: C/O SOFINNOVE VENTURE PARTNERS INC STREET 2: 140 GEARY BLVD 10TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trius Therapeutics Inc CENTRAL INDEX KEY: 0001356857 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201320630 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-452-0370 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd331179.xml X0304 4 2012-01-18 0 0001356857 Trius Therapeutics Inc TSRX 0001202793 POWELL MICHAEL C/O SOFINNOVA VENTURES 2800 SAND HILL ROAD, SUITE 150 MENLO PARK CA 94025 1 0 0 0 Common Stock 2012-01-18 4 S 0 4300 5.5569 D 115700 I See Footnote. Common Stock 2012-01-19 4 S 0 2600 5.6392 D 113100 I See Footnote. Common Stock 28 I See Footnote. Shares are owned directly by Sofinnova Management VII, L.L.C. ("SV VII LLC"), the general partner of Sofinnova Venture Partners VII, L.P. ("SV VII"), and Michael Powell, a director of the issuer, James Healy and Eric Buatois, the managing members of SV VII LLC (together, the "Managing Members"), may be deemed to have shared voting and dispositive power over the shares owned by SV VII LLC. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SV VII LLC on December 22, 2011, as amended. Accumulated fractional shares held by SV VII. Shares are owned directly by SV VII. SV VII LLC, the general partner of SV VII, and the Managing Members, may be deemed to have shared voting and dispositive power over the shares owned by SV VII. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.43 to $5.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (5) and (6) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.60 to $5.69, inclusive The reporting person disclaims benefical ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose. /s/ Nathalie Auber, Attorney-in-Fact for Michael Powell 2012-01-20